The AstraZeneca Open Innovation Partnership provides an opportunity for researchers at the University of Adelaide to collaborate with AZ’s industry-leading scientists and develop new medicines.
Researchers are provided access to AstraZeneca’s optimised compounds, technologies, multi-disciplinary science, high-through screening libraries, services and know-how, with the aims of publishing jointly in high profile journals, formulating drug development and commercialisation plans, and seeing their ideas develop into treatments for patients.
Key Dates for Submission
- Concept proposals are due 22 July 2016, followed by shortlisting and an invitation to present a Full Proposal.
- Final decisions will be announced mid November 2016.
Note: this scheme is administered by Adelaide Enterprise (formerly Adelaide Research & Innovation)
Full details including the application template are available at: